Cleveland Diagnostics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 114

Employees

  • Latest Deal Type
  • Series E1

  • Latest Deal Amount
  • $14.4M

  • Investors
  • 9

Cleveland Diagnostics General Information

Description

Developer of a blood-based cancer diagnostics platform designed for early disease detection. The company's technology measures structural differences in proteins to identify biomarkers from cancer cells, enabling healthcare providers to reduce unnecessary biopsies and differentiate between high-risk and low-risk patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3615 Superior Avenue
  • Suite 4406A
  • Cleveland, OH 44114
  • United States
+1 (216)
Primary Industry
Diagnostic Equipment
Corporate Office
  • 3615 Superior Avenue
  • Suite 4406A
  • Cleveland, OH 44114
  • United States
+1 (216)

Cleveland Diagnostics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cleveland Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series E1) 20-Oct-2025 $14.4M Completed Generating Revenue
9. Later Stage VC (Series E) 16-Jan-2024 Completed Generating Revenue
8. Later Stage VC (Series D) 22-Feb-2023 Completed Generating Revenue
7. Later Stage VC (Series D) 09-Feb-2021 Completed Generating Revenue
6. Debt - PPP 07-Apr-2020 Completed Generating Revenue
5. Later Stage VC (Series C) Completed Generating Revenue
4. Early Stage VC 12-Dec-2017 Cancelled Generating Revenue
3. Early Stage VC (Series B) 21-Nov-2016 Completed Generating Revenue
2. Early Stage VC (Series A) 11-Mar-2015 $1.98M $1.98M Completed Startup
1. Spin-Off 06-Nov-2013 Completed Startup
To view Cleveland Diagnostics’s complete valuation and funding history, request access »

Cleveland Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E-1
Series E-2
Series D
Series C
Series B 1,459,271 $0.000100 8% $1.57 $1.57 1x $1.57 2.55%
Series A 2,385,244 $0.000100 8% $0.83 $0.83 1x $0.83 4.17%
To view Cleveland Diagnostics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cleveland Diagnostics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a blood-based cancer diagnostics platform designed for early disease detection. The company's technology me
Diagnostic Equipment
Cleveland, OH
114 As of 2026

Nehren, Germany
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cleveland Diagnostics Competitors (23)

One of Cleveland Diagnostics’s 23 competitors is Hain Lifescience, a Corporate Backed or Acquired company based in Nehren, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Hain Lifescience Corporate Backed or Acquired Nehren, Germany
Foundation Medicine Formerly VC-backed Boston, MA
Boreal Genomics Formerly VC-backed Vancouver, Canada
Decipher Urologic Cancers Formerly VC-backed San Diego, CA
Genalyte Venture Capital-Backed San Diego, CA
You’re viewing 5 of 23 competitors. Get the full list »

Cleveland Diagnostics Patents

Cleveland Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026122608-A1 Systems and methods for analyte assessment, regardless of competing binders Pending 04-Dec-2024
AU-2022377268-A1 Partitioning systems and methods for determining multiple types of cancers Pending 28-Oct-2021
CA-3236536-A1 Partitioning systems and methods for determining multiple types of cancers Pending 28-Oct-2021
EP-4423506-A1 Partitioning systems and methods for determining multiple types of cancers Pending 28-Oct-2021
US-11796544-B1 Partitioning systems and methods for determining multiple types of cancers Active 28-Oct-2021 G01N33/57585
To view Cleveland Diagnostics’s complete patent history, request access »

Cleveland Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cleveland Diagnostics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Serial Stage Venture Partners Venture Capital Minority
Shanghai Creation Investment Management Venture Capital Minority
Novo Holdings Venture Capital Minority
Nottingham Unlimited Ventures Venture Capital Minority
Cleveland Clinic Ventures Corporate Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Cleveland Diagnostics FAQs

  • When was Cleveland Diagnostics founded?

    Cleveland Diagnostics was founded in 2013.

  • Where is Cleveland Diagnostics headquartered?

    Cleveland Diagnostics is headquartered in Cleveland, OH.

  • What is the size of Cleveland Diagnostics?

    Cleveland Diagnostics has 114 total employees.

  • What industry is Cleveland Diagnostics in?

    Cleveland Diagnostics’s primary industry is Diagnostic Equipment.

  • Is Cleveland Diagnostics a private or public company?

    Cleveland Diagnostics is a Private company.

  • What is the current valuation of Cleveland Diagnostics?

    The current valuation of Cleveland Diagnostics is .

  • What is Cleveland Diagnostics’s current revenue?

    The current revenue for Cleveland Diagnostics is .

  • How much funding has Cleveland Diagnostics raised over time?

    Cleveland Diagnostics has raised $126M.

  • Who are Cleveland Diagnostics’s investors?

    Serial Stage Venture Partners, Shanghai Creation Investment Management, Novo Holdings, Nottingham Unlimited Ventures, and Cleveland Clinic Ventures are 5 of 9 investors who have invested in Cleveland Diagnostics.

  • Who are Cleveland Diagnostics’s competitors?

    Hain Lifescience, Foundation Medicine, Boreal Genomics, Decipher Urologic Cancers, and Genalyte are some of the 23 competitors of Cleveland Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process